Some prescribers will now use tamoxifen for up to 10 years instead of 5 years

February 2013

Some prescribers will now use tamoxifen for up to 10 years instead of 5 years...to further reduce the risk of recurrent breast cancer.

Tamoxifen (Nolvadex, etc) is best in PREmenopausal women...and aromatase inhibitors (Arimidex, etc) in POSTmenopausal women.

Aromatase inhibitors aren't effective for premenopausal women...because these women produce too much estrogen.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote